Israel - hebraico - Ministry of Health

שמעון שסטוביץ בעמ - היגיינת הפה

Israel - hebraico - Ministry of Health

beit-erez havat milatin ltd - afoxolaner - טבליות לעיסות - afoxolaner 68 mg

Israel - hebraico - Ministry of Health

abbvie biopharmaceuticals ltd, israel - atogepant as monohydrate - טבליה - atogepant as monohydrate 60 mg - atogepant

Israel - hebraico - Ministry of Health

teva pharmaceutical industries ltd, israel - pravastatin sodium - טבליה - pravastatin sodium 20 mg - pravastatin - pravastatin - pravastatin is indicated as a component of multiple risk factor intervention in those individuals at increased risk for atherosclerotic vascular disease due to hypercholesterolemia . pravastatin should be used in addition to a diet restricted in saturated fat and cholesterol when the response to diet and other nonpharmacological measures alone has been inadequate. *primary prevention of coronary events: in hypercholesterolemic patients whthout clinically evident coronary heart disease pravastatin is indicated to: - reduce the risk of myocardial infarcton. - reduce the risk for revascularization. - reduce the risk of deaths due to cardiovascular causes with no increase in deaths from non-cardiovascular causes. *secondary prevention of cardiovascular events: atherosclerosis: in hypercholesterolemic patients with clinically evident coronary artery disease including prior mi pravastatin is indicated to: - slow the progression of coronary atherosclerosis. - reduce the risk of acute coronary events. myocardial infa

Israel - hebraico - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ziprasidone as hydrochloride monohydrate - קפסולות - ziprasidone as hydrochloride monohydrate 60 mg - ziprasidone - ziprasidone - • schizophrenia. treatment of schizophrenia and for maintenance of clinical improvement during continuation therapy. • bipolar mania. ziprasidone is indicated as monotherapy in the treatment of manic or mixed episodes associated with bipolar disorder with or without psychotic features.• bipolar disorder. maintenance treatment of bipolar disorder, as an adjunct to lithium or valproate.

Israel - hebraico - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ziprasidone as hydrochloride monohydrate - קפסולות - ziprasidone as hydrochloride monohydrate 20 mg - ziprasidone - ziprasidone - • schizophrenia. treatment of schizophrenia and for maintenance of clinical improvement during continuation therapy. • bipolar mania. ziprasidone is indicated as monotherapy in the treatment of manic or mixed episodes associated with bipolar disorder with or without psychotic features.• bipolar disorder. maintenance treatment of bipolar disorder, as an adjunct to lithium or valproate.

Israel - hebraico - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ziprasidone mesylate trihydrate - אבקה להכנת תמיסה לזריקה - ziprasidone mesylate trihydrate 40.93 mg - ziprasidone - ziprasidone - rapid control of agitation in patients with schizophrenia, when oral therapy is not appropriate, for a maximum of 3 consecutive days.

Israel - hebraico - Ministry of Health

eli lilly israel ltd, israel - duloxetine as hydrochloride - קפסולות - duloxetine as hydrochloride 20 mg - duloxetine - duloxetine - yentreve is indicated for women for the treatment of moderate to severe stress urinary incontinence (sui).

Israel - hebraico - Ministry of Health

cure medical & technical supply - aminoacetic acid; aminoacetic acid; calcium chloride dihydrate; fish oil; glucose monohydrate; l- alanine; l- isoleucine; l- leucine; l- lysine acetate; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium sulfate heptahydrate; olive oil; potassium chloride; sodium acetate trihydrate; sodium glycerophosphate hydrate; soya oil; taurine; triglycerides, medium-chain; zinc sulfate heptahydrate - תחליב לאינפוזיה - glucose monohydrate 143 g / 1000 ml; soya oil 60 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml; olive oil 50 g / 1000 ml; fish oil 30 g / 1000 ml; l- alanine 14.0 g / 1000 ml; l-arginine 12.0 g / 1000 ml; l-histidine 3.0 g / 1000 ml; l- isoleucine 5.0 g / 1000 ml; l- leucine 7.4 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- serine 6.5 g / 1000 ml; taurine 1.0 g / 1000 ml; l- threonine 4.4 g / 1000 ml; l- tryptophan 2.0 g / 1000 ml; l- tyrosine 0.4 g / 1000 ml; l- valine 6.2 g / 1000 ml; calcium chloride dihydrate 0.74 g / 1000 ml; sodium glycerophosphate hydrate 4.18 g / 1000 ml; magnesium sulfate heptahydrate 2.47 g / 1000 ml; potassium chloride 4.48 g / 1000 ml; sodium acetate trihydrate 5.62 g / 1000 ml; zinc sulfate heptahydrate 0.023 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; aminoacetic acid 11.0 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; aminoacetic acid 11.0 g / 1000 ml - parenteral nytrition for adult patients when oral or enteral nutrition is impossible, insufficient or contraindicated.

Israel - hebraico - Ministry of Health

teva pharmaceutical industries ltd, israel - atorvastatin as calcium - טבליה - atorvastatin as calcium 20 mg - atorvastatin